NCT04560673 2025-12-31
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
M.D. Anderson Cancer Center
Phase 2 Recruiting
Clinical Trials
5 trialsNCT04970121 2024-09-25
Efficacy and Safety of Duloxetine in Chinese Solid Tumor Patients with Taxanes-induced Painful Peripheral Neuropathy
The First Affiliated Hospital of Bengbu Medical University
Phase 2 Recruiting
NCT06551051 2024-09-19
ADC-induced Neurotoxicity Treated With Duloxetine
Fudan University
Phase 2 Recruiting
NCT01912612 2020-08-06
Mechanistic Study of Duloxetine in Breast Cancer Patients With Chronic Pain
University of Michigan Rogel Cancer Center
Phase 2 Completed
NCT04294953 2020-03-04
Efficacy of Perioperative Duloxetine as a Part of Multimodal Analgesia in Laparoscopic Colorectal Cancer Surgery
Assiut University
Phase 2 Unknown